P0244 : Thieno-triazolodiazepines block hepatocarcinoma progression by HSP-dependent kinoma inhibition von Ceni, E, Tarocchi, M, Polvani, S, Marroncini, G, Tempesti, S, Mello, T, Galli, A

Volltext

P67 PAF-RECEPTOR INHIBITORS HAVE AN ANTI-PROLIFERATIVE EFFECT ON HEPATOCELLULAR CARCINOMA CELLS von Tarocchi, M, Marroncini, G, Polvani, S, Mello, T, Tempesti, S, Ceni, E, Galli, A

Volltext

P0940 : Chronic particulate matter exposition represents a second hit in the progression from steatosis to steatohepatitis von Tarocchi, M, Marroncini, G, Polvani, S, Tempesti, S, Ceni, E, Mello, T, Peluso, M, Galli, A

Volltext

In vivo effects of rosiglitazone in a human neuroblastoma xenograft von Cellai, I, Petrangolini, G, Tortoreto, M, Pratesi, G, Luciani, P, Deledda, C, Benvenuti, S, Ricordati, C, Gelmini, S, Ceni, E, Galli, A, Balzi, M, Faraoni, P, Serio, M, Peri, A

Volltext

Pharmacological inhibition of Sirt1 promotes apoptosis and senescence of hepatic stellate cells during liver injury von Tarocchi, M, Marroncini, G, Ceni, E, Polvani, S, Tempesti, S, Mello, T, Galli, A

Volltext

Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARγ independent mechanisms von Galli, A, Ceni, E, Crabb, D W, Mello, T, Salzano, R, Grappone, C, Milani, S, Surrenti, E, Surrenti, C, Casini, A

Volltext

The two Thieno-triazolodiazepines WEB 2086 and WEB 2170 block Hepatocarcinoma progression by Hsp-dependent client kinoma protein ubiquitination von Ceni, E, Malentacchi, C, Tarocchi, M, Marroncini, G, Polvani, S, Mello, T, Tempesti, S, Galli, A

Volltext

Chronic particulate matter exposition and western diet induce the progression from steatosis to steatohepatitis von Tarocchi, M, Marroncini, G, Polvani, S, Tempesti, S, Ceni, E, Mello, T, Peluso, M, Galli, A

Volltext

SIRT1 activity in hepatic stellate cells during liver injury is a target for the modulation of the fibrogenic process von Tarocchi, M, Marroncini, G, Mello, T, Polvani, S, Tempesti, S, Ceni, E, Galli, A

Volltext

PAF-receptor antagonists reduce HCC progression blocking cancer cell proliferation and migration von Tarocchi, M, Ceni, E, Marroncini, G, Polvani, S, Tempesti, S, Mello, T, Galli, A

Volltext

Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression von Mello, T, Zanieri, F, Materozzi, M, Bereshchenko, O, Ceni, E, Tarocchi, M, Marroncini, G, Polvani, S, Tempesti, S, Nerlov, C, Milani, S, Galli, A

Volltext

Neutrophil‐derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: Role of nitric oxide von Casini, A, Ceni, E, Salzano, R, Biondi, P, Parola, M, Galli, A, Foschi, M, Caligiuri, A, Pinzani, M, Surrenti, C

Volltext

P.01.2 PAF-RECEPTOR ANTAGONISTS INHIBIT HEPATOCELLULAR CARCINOMA GROWTH von Ceni, E, Tarocchi, M, Polvani, S, Mello, T, Marroncini, G, Tempesti, S, Lisi, F, Dei, S, Galli, A

Volltext

P.01.4 ADAM-9 EXPRESSION MEDIATES COUP-TFII-DEPENDENT INVASIVENESS OF PANCREATIC CANCER CELLS von Ceni, E, Mello, T, Tarocchi, M, Polvani, S, Buccoliero, F, Tempesti, S, Marroncini, G, Galli, A

Volltext

The AAA+ ATPase Ruvbl1 coordinates liver metabolism and hepatocellular carcinoma progression von Mello, T, Materozzi, M, Zanieri, F, Bereshchenko, O, Ceni, E, Tarocchi, M, Marroncini, G, Simeone, I, Polvani, S, Tempesti, S, Nerlov, C, Milani, S, Galli, A

Volltext

Antagonistic signalling by PPARgamma and rosiglitazone converge on Ruvbl1 regulation in HCC cells von Mello, T, Tarocchi, M, Perini, F, Buccoliero, F, Marroncini, G, Ceni, E, Polvani, S, Tempesti, S, Milani, S, Galli, A

Volltext

313 TELOMERASE ACTIVATED THYMIDINE ANALOGUE PROD-DRUG PREVENTS GROWTH AND INDUCES REGRESSION IN TWO IN VIVO MODELS OF HEPATOCELLULAR CARCINOMA von Tarocchi, M, Polvani, S, Calamante, M, Mello, T, Buccoliero, F, Ceni, E, Luchinat, C, Bertini, I, Milani, S, Galli, A

Volltext

400 IMPORTANT ROLE OF SIRT1 IN THE SURVIVAL AND ACTIVATION OF HEPATIC STELLATE CELLS DURING LIVER INJURY von Tarocchi, M, Vellei, S, Buccoliero, F, Mello, T, Polvani, S, Ceni, E, Milani, S, Galli, A

Volltext

PC.02.2 TARGET THERAPY: A TELOMERASE ACTIVATED THYMIDINE ANALOGUE PRO-DRUG FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA von Tarocchi, M, Polvani, S, Peired, A, Marroncini, G, Mello, T, Buccoliero, F, Ceni, E, Milani, S, Galli, A

Volltext

OC.05.3 ROSIGLITAZONE REDUCES THE IN VITRO AND IN VIVO ONCOGENIC POTENTIAL OF HCC CELLS THROUGH A PPARGAMMA-INDEPENDENT NON-GENOMIC INHIBITION OF RUVBL-1 von Mello, T, Tarocchi, M, Buccoliero, F, Ceni, E, Polvani, S, Milani, S, Galli, A

Volltext